Natural Plant Compound Shows Promise for Treating Gum Disease
A natural compound called morin, found in fruits, teas, and nuts, is showing promise as a new tool…
Tylenol’s 70-year history: From kids’ drug to political controversy
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT…
Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with…
Study Finds Common Meds Leave Lasting Imprints on the Gut, Even Years After You Stop Taking Them
Medications may leave microbial “fingerprints” that last years after use, according to new research from the University of…
Twice-a-year injection could make HIV prevention easier, developer argues
A twice-a-year shot for HIV prevention could make it easier for people to protect themselves from the virus,…
Researchers Use Synchrotron X-Rays to Identify Promising Candidate in the Battle Against Antibiotic Resistance
BYLINE: Carol Tseng Newswise — Alexander Fleming’s accidental discovery of penicillin in 1928 changed the world: Once-common bacterial…
Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome
NEEDHAM, Mass., Sept. 19, 2025 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a commercial-stage biotechnology company focused…
Chemical Discovery Could Lower Prescription Drug Costs
A new sustainable method to produce pharmaceuticals could help to lower prescription drug costs in the U.S. This…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
Construction begins for the Berlin Center for Gene and Cell Therapies
Berlin, September 16, 2025 – A groundbreaking ceremony kicked off the construction work for the Berlin Center for…
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer look
Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…